Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor
NCT: NCT05755399 · RECRUITING
Brief Summary
Transcranial focused ultrasound (tFUS) offers a platform for non-invasive imaging and treatment of the brain and pathology of the brain -- allowing high resolution imaging in both spatial and temporal dimensions. Compared with the gold- standard for brain imaging, magnetic resonance imaging (MRI), ultrasound offers reduced contrast while providing improved sampling in time through a significantly more cost-effective approach. In addition, while MRI is used to guide invasive treatments, only ultrasound can offer treatments through three primary mechanisms: 1) neuromodulation, 2) blood brain barrier modulation, and thermal/mechanical ablation through high intensity focused ultrasound (HIFU). All three treatment options require targeting therapy through the skull, which remains a barrier to clinical translation. This proposal is to test the feasibility of acquiring noninvasive targeting imaging intraoperatively prior to clinically indicated cranial neurosurgery. By acquiring volumetric ultrasound images while coregistered to previously obtained stereotactic magnetic resonance imaging, the study will be able to compare the ability of tFUS to identify and focus on brain pathology.
Frequently Asked Questions
What is Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor?
Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor is a clinical trial registered under NCT05755399. Current status: RECRUITING.
What is the status of NCT05755399?
The current status of NCT05755399 (Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor) is: RECRUITING.
When did Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor start?
Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor started on 2023-10-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.